Haemophilus Influenzae Type B Hib
Mostrando 1-12 de 137 artigos, teses e dissertações.
-
1. Invasive Haemophilus influenzae disease in the vaccine era in Rio de Janeiro, Brazil
BACKGROUND Haemophilus influenzae (Hi) serotype b (Hib) conjugate vaccine was incorporated into the infant immunisation schedule in Brazil in 1999, where Hib was one of the major etiologic sources of community-acquired bacterial meningitis. OBJECTIVES The purpose of this study is to describe the molecular epidemiology of invasive Hi disease in Rio de Jane
Mem. Inst. Oswaldo Cruz. Publicado em: 16/02/2017
-
2. Estratégias de cultivo para a produção de polissacarídeo capsular por Haemophilus influenzae tipo b e determinação de parâmetros de qualidade para o produto / Cultivation strategies for capsular polysaccharide production by Haemophilus influenzae type b and determination of quality parameters for the product
Haemophilus influenzae tipo b (Hib) é uma bactéria Gram negativa responsável por causar meningite em todo o mundo. O polissacarídeo capsular b, um polímero composto por unidades repetidas de ribosil-ribitol-fosfato (PRP) e o principal fator de virulência, sendo utilizado na formulação da vacina contra este microrganismo. Apesar de sua elevada eficiê
Publicado em: 2010
-
3. Pattern of functional antibody activity against Haemophilus influenzae type b (Hib) in infants immunized with diphtheria-tetanus-pertussis/Hib Brazilian combination vaccine
We evaluated the functional activity of Haemophilus influenzae B (Hib) antibodies elicited in a group of infants immunized with the diphtheria-tetanus-pertussis vaccine combined with an Hib vaccine produced totally in Brazil after technological transfer of Hib vaccine production from Glaxo SmithKline, Belgium. Blood samples from immunized infants (N = 985) w
Brazilian Journal of Medical and Biological Research. Publicado em: 06/11/2009
-
4. Immunogenicity, reactogenicity and consistency of production of a Brazilian combined vaccine against diphtheria, tetanus, pertussis and Haemophilus influenzae type b
A randomized, double-blinded study evaluating the immunogenicity, safety and consistency of production of a combined diphtheria-tetanus-pertussis-Haemophilus influenzae type b vaccine entirely produced in Brazil by Bio-Manguinhos and Instituto Butantan (DTP/Hib-BM) was undertaken. The reference vaccine had the same DTP vaccine but the Hib component was produ
Memórias do Instituto Oswaldo Cruz. Publicado em: 2008-11
-
5. Placental transfer of Haemophilus influenzae type b antibodies in malnourished pregnant women
This study evaluated the vaccination response to Haemophilus influenzae type b (Hib) in malnourished pregnant women (MN), cord blood (CB) and in infants at two and six months of age for comparison with a control group (C). Twenty-eight malnourished pregnant women and 29 pregnant controls were immunized with conjugated Act-HIB® in the third trimester of preg
Brazilian Journal of Infectious Diseases. Publicado em: 2008-02
-
6. Avaliação da transferência materno-infantil de anticorpos séricos e secretores dirigidos ao polissacarídeo da cápsula de Haemophilus influenzae tipo B (HIB) em amostras pré e pós-vacinais de mães com PRP conjugado ao toxóide tetânico (PRP-T). / Avaliation of maternal-infant transfer of seric and secretory antibodies reactive to capsule polysaccharides Haemophilus influenzae type b (Hib) in pre and post vaccine samples of immunized mothers in PRP conjugate with tetanic toxóide (PRP-T).
Introdução: O Haemophilus influenzae type b (Hib) é a primeira maior causa de meningites e pneumonias provocadas por bactérias encapsuladas. Trabalhos revelam que anticorpos maternos, séricos e secretores, podem proteger recém nascidos (RN) destes patógenos encapsulados e contribuem para a maturação do sistema imune do infante. Objetivo: O presente
Publicado em: 2008
-
7. Meningite por Haemophilus influenzae em Salvador, Bahia: aspectos do período pré e pós vacinal. / Haemophilus influenzae meningitis in Salvador, Bahia: features from before and after vaccine implementation.
Introduction of polysaccharide conjugate vaccines against Haemophilus influenzae type b (Hib) was a major public health advances, practically eliminating the Hib meningitis in coutries where it was implemented. The aims of this work were to describe the H. influenzae meningitis in Salvador, Bahia, looking for the impact of vaccination, and to characterize no
Publicado em: 2007
-
8. Vacinação contra Haemophilus influenzae tipo b: proteção a longo prazo
OBJETIVO: Identificar as evidências sobre o impacto da vacina conjugada para Haemophilus influenzae tipo b (Hib) na epidemiologia da doença invasiva por Hib. FONTE DOS DADOS: Pesquisa nas bases de dados do MEDLINE, LILACS, publicações técnicas de organizações internacionais, diretrizes nacionais e internacionais, nos últimos 15 anos (1991-2005), util
Jornal de Pediatria. Publicado em: 2006-07
-
9. Immunogenicity of a combined DTPa-HB vaccine co-administered with Haemophilus influenzae type B conjugate vaccine (PRP-T) for primary and booster vaccinations
OBJECTIVE: To evaluate the immunogenicity of a combined DTPa-HB vaccine co-administered with Haemophilus influenzae type b conjugate vaccine (PRP-T) in Brazilian infants. MATERIAL AND METHODS: A prospective and open clinical study, in which 110 infants were immunized with a three-dose primary vaccination regime at two, four and six months of age and with a s
Brazilian Journal of Infectious Diseases. Publicado em: 2005-10
-
10. Occurrence of Haemophilus influenzae strains in three Brazilian states since the introduction of a conjugate Haemophilus influenzae type b vaccine
Few vaccines in history have induced such a dramatic decline in incidence over such a short period of time as the Haemophilus influenzae type b (Hib) conjugate. This vaccine was introduced in 1988 in the United States, but only in 1999 was Hib immunization introduced by the Brazilian Ministry of Health as part of the routine infant National Immunization Prog
Brazilian Journal of Medical and Biological Research. Publicado em: 2005-05
-
11. Naturally acquired immunity to Haemophilus influenzae type B in healthy Cuban children
We have evaluated the prevalence of antibody to immunogenicity of Haemophilus influenzae type b (Hib) in a group of 4 to 5 years old healthy children, who were too old to be included in the first vaccinated cohort when Hib vaccination begun in Cuba in 1999. Serum capsular polysaccharide specific IgG antibody concentrations were measured in 974 healthy childr
Memórias do Instituto Oswaldo Cruz. Publicado em: 2004-11
-
12. Colonização da orofaringe de crianças saudáveis de Taubaté (São Paulo) por Haemophilus influenzae, antes da introdução da vacina contra Haemophilus influenzae do tipo b no Brasil
Haemophilus influenzae é um dos mais importantes agentes bacterianos de otites e sinusites. Em crianças menores de seis anos de idade não vacinadas contra o H. influenzae do tipo b (Hib), essa bactéria é uma das principais causadoras de meningite, pneumonia e sepse. O objetivo deste estudo foi determinar a prevalência da colonização da orofaringe de
Revista do Hospital das Clínicas. Publicado em: 2004